Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients
Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients have?
Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients has 12 citations in the OpenAlex counts ScholarIQ stores.
When was Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients published?
Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients has 2023 year in the ScholarIQ index.
What is the open-access status of Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients?
Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients has closed oa status in the ScholarIQ index.
What is the DOI of Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients?
The DOI for Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients is on the source record.
What is the PMID of Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients?
The PMID for Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients is on the source record.
What is the OpenAlex record for Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients?
The OpenAlex for Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients is on the source record.